Evidence map›Paper›PMID 40303790›Full record

ArticleTransboundary and emerging diseases2023

Field Evaluation of a Safe, Easy, and Low-Cost Protocol for Shipment of Samples from Suspected Cases of Foot-and-Mouth Disease to Diagnostic Laboratories.

Aurore Romey, Hussaini G Ularamu, Abdulnaci Bulut, Syed M Jamal, Salman Khan, Muhammad Ishaq, Michael Eschbaumer, Graham J Belsham, Cindy Bernelin-Cottet, Anthony Relmy and 8 more

Abstract read
In one paragraph

Article in Transboundary and emerging diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Aurore RomeyAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.ORCID https://orcid.org/0000-0002-0139-5142
Hussaini G UlaramuFMD Research Centre, National Veterinary Research Institute (NVRI), PMB 01 Vom, Lagos, Nigeria.
Abdulnaci BulutSAP/FMD Institute, Dumlupinar Bulvard 35, Ankara 06510, Turkey.
Syed M JamalDepartment of Biotechnology, University of Malakand, Chakdara 18800, Khyber Pakhtunkhwa, Pakistan.ORCID https://orcid.org/0000-0002-0768-4471
Salman KhanDepartment of Biotechnology, University of Malakand, Chakdara 18800, Khyber Pakhtunkhwa, Pakistan.
Muhammad IshaqDepartment of Biotechnology, University of Malakand, Chakdara 18800, Khyber Pakhtunkhwa, Pakistan.ORCID https://orcid.org/0000-0003-1109-6549
Michael EschbaumerInstitute of Diagnostic Virology, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, Greifswald 17489, Germany.
Graham J BelshamDTU National Veterinary Institute, Technical University of Denmark, Lindholm, Kalvehave DK-4771, Denmark.ORCID https://orcid.org/0000-0003-1187-4873
Cindy Bernelin-CottetAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.
Anthony RelmyAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.
Mathilde GondardAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.ORCID https://orcid.org/0000-0002-1484-7689
Souheyla BenfridAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.
Yiltawe S WungakFMD Research Centre, National Veterinary Research Institute (NVRI), PMB 01 Vom, Lagos, Nigeria.
Claude HamersThe Veterinary Public Health Center, Boehringer Ingelheim Animal Health, 29 Avenue Tony Garnier, Lyon, 69007, France.
Pascal HudeletThe Veterinary Public Health Center, Boehringer Ingelheim Animal Health, 29 Avenue Tony Garnier, Lyon, 69007, France.
Stéphan ZientaraAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.
Labib Bakkali KassimiAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.
Sandra Blaise-BoisseauAnimal Health Laboratory, Foot-and-Mouth Reference Laboratory, Virology JRU, ANSES, INRAE, ENVA, Paris-Est University, Maisons-Alfort 94700, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Identification and characterization of the foot-and-mouth disease virus (FMDV) strains circulating in endemic countries and their dynamics are essential elements of the global FMD control strategy. Characterization of FMDV is usually performed in reference laboratories (RL). However, shipping of FMD samples to RL is a challenge due to the cost and biosafety requirements of transportation, resulting in a lack of knowledge about the strains circulating in some endemic areas. In order to simplify this step and to encourage sample submission to RL, we have previously developed a low-cost protocol for the shipment of FMD samples based on the use of lateral flow devices (LFDs) combined with a simple virus inactivation step using 0.2% citric acid. The present study aimed to evaluate this inactivation protocol in the field. For this purpose, 60 suspected FMD clinical samples were collected in Nigeria, Pakistan, and Turkey, three countries where FMD is endemic. Sample treatment, testing on LFDs, and virus inactivation steps were performed in the field when possible. The effectiveness of the virus inactivation was confirmed at the RL. After RNA extraction from the 60 inactivated LFDs, all were confirmed as FMDV positive by real-time reverse transcription polymerase chain reaction (RT-PCR). The serotype was identified by conventional RT-PCR for 86% of the samples. The topotype and/or lineage was successfully determined for 60% of the samples by Sanger sequencing and sequence analyses. After chemical transfection of RNA extracted from inactivated LFDs, into permissive cells, infectious virus was rescued from 15% of the samples. Implementation of this user-friendly protocol can substantially reduce shipping costs, which should increase the submission of field samples and therefore improve knowledge of the circulating FMDV strains.

Indexed as

Cattle DiseasesFoot-and-Mouth DiseaseFoot-and-Mouth Disease VirusSpecimen HandlingTransportationAnimalsCattlePakistanVirus Inactivation

Identifiers

PMID40303790
PMCPMC12016716

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.